4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-031074
Chief Executive Officer sold 4,536 shares at $4.21 ($19,115)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Brainard Diana · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-05-18 | Sale : show line 1 in the form 10b5-1 | −4,536 | $4.21 | $19,115 | 916,628 | D |
| Open-market sales · 4,536 sh · avg $4.21 · $19,115 | ||||||
Loading xslF345X04/doc4.xml…